Grufity logoGrufity logo

Irhythm Technologies Inc Stock Research

IRTC

121.21USD+1.98(+1.66%)Market Closed

Market Summary

USD121.21+1.98
Market Closed
1.66%

IRTC Alerts

IRTC Stock Price

IRTC RSI Chart

IRTC Valuation

Market Cap

3.7B

Price/Earnings (Trailing)

-31.51

Price/Sales (Trailing)

8.91

EV/EBITDA

-36.41

Price/Free Cashflow

-69.26

IRTC Price/Sales (Trailing)

IRTC Profitability

Operating Margin

68.54%

EBT Margin

-28.20%

Return on Equity

-48.44%

Return on Assets

-25.91%

Free Cashflow Yield

-1.44%

IRTC Fundamentals

IRTC Revenue

Revenue (TTM)

410.9M

Revenue Y/Y

37.67%

Revenue Q/Q

8.42%

IRTC Earnings

Earnings (TTM)

-116.2M

Earnings Y/Y

37.84%

Earnings Q/Q

5.84%

Price Action

52 Week Range

85.74169.54
(Low)(High)

Last 7 days

5.7%

Last 30 days

12.5%

Last 90 days

27.3%

Trailing 12 Months

-16.5%

IRTC Financial Health

Current Ratio

3.24

Debt/Equity

0.04

Debt/Cashflow

-3.57

IRTC Investor Care

Shares Dilution (1Y)

2.37%

Diluted EPS (TTM)

-3.88

Peers (Alternatives to Irhythm Tech)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
104.7B
18.4B
5.75% 5.84%
44.4
5.68
7.84% 18.25%
89.7B
6.2B
9.79% -8.77%
67.87
14.42
8.97% -22.43%
69.0B
12.7B
3.45% 12.48%
98.9
5.44
6.68% -32.95%
68.2B
19.0B
0.04% -5.99%
42.3
3.59
-0.43% -8.78%
49.1B
5.4B
7.07% -26.22%
32.28
9.13
2.86% 1.25%
MID-CAP
7.2T
489.7M
11.64% 12.09%
82.2K
16.8K
106.51% 2464.23%
10.5B
847.1M
5.10% 33.54%
-5.2K
12.36
13.32% -137.89%
5.3B
1.0B
-10.58% -23.27%
30.73
5.18
6.76% 24.45%
3.7B
410.9M
12.45% -16.48%
-31.51
8.91
27.29% -14.60%
2.7B
801.2M
5.14% -62.54%
-28.72
3.39
14.00% -707.69%
SMALL-CAP
1.7B
350.9M
10.32% 47.03%
-11.09
4.81
44.26% -5.42%
1.5B
138.6M
-27.91% -1.63%
-26.56
10.54
36.62% -10.44%
1.3B
820.0M
-1.92% -12.15%
26.32
1.62
10.13% 701.59%
832.6M
239.8M
0.71% -3.36%
-21.99
3.47
-4.74% -31.15%

Financials for Irhythm Tech

Income Statement (Last 12 Months)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue8.1%410,921,000380,108,000361,665,000340,892,000322,825,000
Gross Profit10.8%281,632,000254,208,000239,435,000224,473,000213,567,000
Operating Expenses4.2%395,416,000379,493,000366,916,000345,495,000313,510,000
  S&GA Expenses4.9%322,198,000307,080,000297,266,000278,184,000274,839,000
  R&D Expenses1.8%46,610,00045,805,00043,042,00040,703,00038,671,000
EBITDA12.0%-98,343,000-111,816,000-115,310,000-110,108,000-
EBITDA Margin18.6%-0.24-0.29-0.32-0.32-
Earnings Before Taxes9.6%-115,886,000-128,193,000-130,495,000-123,875,000-100,994,000
EBT Margin16.4%-0.28-0.34-0.36-0.36-
Interest Expenses22.7%4,138,0003,373,0003,038,0002,863,0001,169,000
Net Income9.6%-116,155,000-128,448,000-130,728,000-124,191,000-101,361,000
Net Income Margin16.4%-0.28-0.34-0.36-0.36-
Free Cahsflow30.5%-52,842,000-75,995,000-68,962,000-64,224,000-
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets1.8%448440436429463
  Current Assets1.0%289286285286306
    Cash Equivalents10.7%79.0071.0010195.00128
  Inventory4.9%15.0014.0014.0012.0010.00
  Net PPE5.8%76.0072.0066.0057.0056.00
  Goodwill0%1.001.001.001.001.00
Liabilities3.6%208201191184183
  Current Liabilities6.6%89.0084.0070.0062.0088.00
  Long Term Debt-10.00----
    LT Debt, Non Current0.0%35.0035.0035.0035.0010.00
Shareholder's Equity0.2%240239245245280
  Retained Earnings-4.0%-522-502-480-456-406
  Additional Paid-In Capital2.8%762742726702686
Accumulated Depreciation9.6%32.0029.0026.0023.00-
Shares Outstanding0.3%30.0030.0030.0030.0029.00
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations52.7%-23.01-48.63-34.62-34.80-37.75
  Share Based Compensation7.3%58.0054.0053.0048.0055.00
Cashflow From Investing26.6%-52.43-71.45-22.43-20.30105
Cashflow From Financing11.6%27.0024.0019.0013.00-28.58

Risks for IRTC

What is the probability of a big loss on IRTC?

89.6%


Probability that Irhythm Tech stock will be more than 20% underwater in next one year

71.9%


Probability that Irhythm Tech stock will be more than 30% underwater in next one year.

30.4%


Probability that Irhythm Tech stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does IRTC drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Irhythm Tech was unfortunately bought at previous high price.

Drawdowns

Returns for IRTC

Cumulative Returns on IRTC

14.4%


5-Year Cumulative Returns

14.6%


3-Year Cumulative Returns

What are the long-term rolling returns for IRTC?

FIve years rolling returns for Irhythm Tech.

Annualized Returns

Which funds bought or sold IRTC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
added
20.42
-77,062
694,938
-%
2023-03-06
Rockefeller Capital Management L.P.
reduced
-1.91
-68,000
187,000
-%
2023-02-28
Voya Investment Management LLC
unchanged
-
-363,137
1,074,860
-%
2023-02-21
Empowered Funds, LLC
sold off
-100
-1,679,000
-
-%
2023-02-21
MACQUARIE GROUP LTD
reduced
-0.07
-584,000
1,578,000
-%
2023-02-17
TRUIST FINANCIAL CORP
reduced
-2.89
-709,324
1,879,680
-%
2023-02-17
Ascent Group, LLC
unchanged
-
-90,496
251,504
0.03%
2023-02-16
IMA Wealth, Inc.
unchanged
-
-171,182
505,818
0.13%
2023-02-16
HARBOUR INVESTMENTS, INC.
reduced
-52.38
-1,063
937
-%
2023-02-15
HOWE & RUSLING INC
sold off
-100
-38,000
-
-%

1–10 of 41

Latest Funds Activity

Are funds buying IRTC calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own IRTC
No. of Funds

Irhythm Tech News

Barchart

Stocks Climb Before The Open As Investors Await Key U.S. GDP ....

Barchart,
31 days ago

Schedule 13G FIlings of Irhythm Tech

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
sands capital management, llc
9.1%
2,667,428
SC 13G/A
Feb 09, 2023
vanguard group inc
9.55%
2,876,849
SC 13G/A
Jan 31, 2023
blackrock inc.
7.6%
2,288,507
SC 13G/A
Jan 27, 2023
mackenzie financial corp
4.14%
1,246,524
SC 13G/A
Feb 14, 2022
sands capital management, llc
10.34%
3,041,867
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
1.7%
524,505
SC 13G/A
Feb 04, 2022
mackenzie financial corp
5.73%
1,685,430
SC 13G/A
Feb 03, 2022
blackrock inc.
7.1%
2,084,707
SC 13G/A
Jan 24, 2022
jpmorgan chase & co
7.0%
2,083,625
SC 13G
Jul 09, 2021
brown capital management llc
0%
0
SC 13G/A

IRTC Fair Value

Irhythm Tech fair value in different scenarios

The table shows the Fair Value estimates for Irhythm Tech for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

4.01

-96.69%

6.61

-94.55%

14.47

-88.06%

29.61

-75.57%

60.33

-50.23%
Current Inflation

3.82

-96.85%

6.12

-94.95%

12.93

-89.33%

25.86

-78.67%

51.96

-57.13%
Very High Inflation

3.57

-97.05%

5.53

-95.44%

11.12

-90.83%

21.51

-82.25%

42.34

-65.07%

Historical Irhythm Tech Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Irhythm Tech

View All Filings
Date Filed Form Type Document
Mar 15, 2023
8-K
Current Report
Mar 10, 2023
8-K
Current Report
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading

Latest Insider Trading transactions for IRTC

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-03
Devine Douglas
sold
-172,680
117
-1,473
chief operating officer
2023-03-03
Murphy Patrick Michael
sold
-66,938
117
-571
clo & evp ra/qa mrktacs & gov
2023-03-03
Wilson Daniel G.
sold
-166,701
117
-1,422
evp, strategy corp dev inv rel
2023-03-03
Day Mark J.
sold
-248,059
117
-2,116
chief technology officer
2023-02-28
Wilson Daniel G.
sold
-203,395
117
-1,726
evp, strategy corp dev inv rel
2023-02-28
Day Mark J.
sold
-225,431
117
-1,913
chief technology officer
2023-02-28
Devine Douglas
sold
-414,563
117
-3,518
chief operating officer
2023-02-27
Shrishrimal Sumi
acquired
-
-
6,961
evp, chief risk officer
2023-02-27
Bobzien Brice
acquired
-
-
9,282
chief financial officer
2023-02-27
Day Mark J.
acquired
-
-
11,822
chief technology officer

1–10 of 50

Quentin S. Blackford
1700
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

IRTC Income Statement

2022-12-31
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]   
Revenue, net$ 410,921$ 322,825$ 265,166
Cost of revenue129,289109,25870,277
Gross profit281,632213,567194,889
Operating expenses:   
Research and development46,61038,67141,329
Selling, general and administrative322,198274,839197,233
Impairment and restructuring charges26,60800
Total operating expenses395,416313,510238,562
Loss from operations(113,784)(99,943)(43,673)
Interest expense(4,138)(1,169)(1,519)
Other income (expense), net2,0361181,591
Loss before income taxes(115,886)(100,994)(43,601)
Income tax provision269367229
Net loss$ (116,155)$ (101,361)$ (43,830)
Net loss per common share, basic (in USD per share)$ (3.88)$ (3.46)$ (1.58)
Net loss per common share, diluted (in USD per share)$ (3.88)$ (3.46)$ (1.58)
Weighted-average shares, basic (in shares)29,915,72029,331,01027,754,404
Weighted-average shares, diluted (in shares)29,915,72029,331,01027,754,404

IRTC Balance Sheet

2022-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 78,832$ 127,562
Short-term investments134,312111,569
Accounts receivable, net49,91846,430
Inventory15,15510,268
Prepaid expenses and other current assets10,5559,693
Total current assets288,772305,522
Property and equipment, net75,67055,944
Operating lease right-of-use assets60,66684,587
Goodwill862862
Other assets22,25216,052
Total assets448,222462,967
Current liabilities:  
Accounts payable7,51710,509
Accrued liabilities65,49751,486
Deferred revenue3,0513,049
Debt, current011,667
Operating lease liabilities, current13,03111,142
Total current liabilities89,09687,853
Debt, noncurrent34,9359,690
Other noncurrent liabilities1,307697
Operating lease liabilities, noncurrent83,07285,212
Total liabilities208,410183,452
Commitments and contingencies (Note 8)
Stockholders’ equity:  
Preferred stock, $0.001 par value – 5,000,000 shares authorized at December 31, 2022 and 2021; and none issued and outstanding at December 31, 2022 and 2021, respectively00
Common stock, $0.001 par value – 100,000,000 shares authorized at December 31, 2022 and 2021; 30,193,101 and 29,493,726 shares issued and outstanding at December 31, 2022 and 2021, respectively2827
Additional paid-in capital762,380685,594
Accumulated other comprehensive income (loss)(396)(61)
Accumulated deficit(522,200)(406,045)
Total stockholders’ equity239,812279,515
Total liabilities and stockholders’ equity$ 448,222$ 462,967